Clinical Trial Update: Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Dual Layer Amniotic Membrane (Artacent) for chronic diabetic foot ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcers

Drugs mentioned

• Artacent™

Snippet

Sponsor: SerenaGroup, Inc. | Conditions: Chronic Diabetic Foot Ulcers | Phase 4 | Status: UNKNOWN